Kimihiro Igari

Dr. Kimihiro Igari

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
KIKimihiro Igari
Kimihiro Igari
TKT. Kudo
T. Kudo
TTT. Toyofuku
T. Toyofuku
MJM. Jibiki
M. Jibiki
YIY. Inoue
Y. Inoue
TKT. Kawano
T. Kawano

27 April 2010 in Hernia
Verified
Journal Article
Closed access
PDF file
KIKimihiro Igari
Kimihiro Igari
TOT. Ochiai
T. Ochiai
AAA. Aihara
A. Aihara
YKY. Kumagai
Y. Kumagai
MIM. Iida
M. Iida
SYS. Yamazaki
S. Yamazaki

1 January 2014 in Annals of Vascular Diseases
Verified
Journal Article
Closed access
KIKimihiro Igari
Kimihiro Igari
NSNorihide Sugano
Norihide Sugano
TKToshifumi Kudo
Toshifumi Kudo
TTTakahiro Toyofuku
Takahiro Toyofuku
MJMasatoshi Jibiki
Masatoshi Jibiki
TITakehisa Iwai
Takehisa Iwai
To evaluate the long-term outcomes of surgical treatment for popliteal artery entrapment syndrome (PAES). This study was undertaken from a retrospective review of case notes of patients treated for PAES between August 1974 and July 2013. We examined patients' characteristics and surgical procedures, and evaluated long-term outcomes including clinical symptoms and graft or native artery patency. Twenty-nine limbs (24 patients, mean age: 32 years) underwent surgery. Popliteal arteries were occluded (n = 18) stenosed (n = 7) and normal (n = 4). Twenty-five limbs required both revasularization (interposition [n = 24] and bypass surgery [n = 1]) and myotomy. Four limbs were treated solely with myotomy. During the long-term follow-up period, three limbs required reoperation. The overall primary graft and native popliteal artery patency rates at one and 5 years were 96.3% and 91.9%, respectively. The treatment of PAES with myotomy and selective revascularization achieves good short- and long-term outcomes. The use of an interposition vein graft reconstruction is associated with minimal morbidity and good long-term patency.

1 January 2016 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
KIKimihiro Igari
Kimihiro Igari
YIYoshinori Inoue
Yoshinori Inoue
TITakehisa Iwai
Takehisa Iwai

1 July 2014 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
KIKimihiro Igari
Kimihiro Igari
TKToshifumi Kudo
Toshifumi Kudo
HUHidetoshi Uchiyama
Hidetoshi Uchiyama
TTTakahiro Toyofuku
Takahiro Toyofuku
YIYoshinori Inoue
Yoshinori Inoue

1 January 2013 in Annals of Vascular Diseases
Verified
Journal Article
Closed access
KIKimihiro Igari
Kimihiro Igari
TTTakahiro Toyofuku
Takahiro Toyofuku
HUHidetoshi Uchiyama
Hidetoshi Uchiyama
SKShinya Koizumi
Shinya Koizumi
KYKoji Yonekura
Koji Yonekura
YIYoshinori Inoue
Yoshinori Inoue
Maggots are potent debriding agents capable of removing necrotic tissue and slough; however, it is still unclear which wounds are most likely to benefit from maggot debridement therapy (MDT). Thus, we performed this retrospective review to gain insight into the patient and therapy characteristics influencing outcome. We reviewed patients with foot ulcers caused by critical limb ischemia, encountered during the period between June 2005 and May 2010. The treatment outcomes were defined as effective or ineffective. There were 16 patients with 16 leg ulcers. The patients were 13 men and 3 women, with an average age of 67.2 years (range, 47-85 years). Ten (63%) of the 16 ulcers were treated effectively. According to univariate analyses, an ankle brachial pressure index (ABI) lower than 0.6 (p = 0.03) had a negative impact on the outcome of MDT; however, outcome was not influenced by gender, obesity, ischemic heart disease, diabetes mellitus, hemodialysis, smoking, or laboratory findings. Some patient characteristics, such as gender, obesity, ischemic heart disease, diabetes mellitus, hemodialysis, and smoking, do not seem to contraindicate eligibility for MDT. However, a limb with an ABI lower than 0.6 is less likely to benefit. (English Translation of J Jpn Coll Angiol 2011; 51: 209-213.).